Emergent BioSolutions, Inc. (EBS)
6.26
+0.39
(+6.64%)
USD |
NYSE |
Sep 11, 14:42
Emergent BioSolutions Gross Profit (TTM) : 363.30M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 363.30M |
| March 31, 2026 | 300.80M |
| December 31, 2025 | 349.70M |
| September 30, 2025 | 363.10M |
| June 30, 2025 | 393.90M |
| March 31, 2025 | 281.90M |
| December 31, 2024 | 304.80M |
| September 30, 2024 | 319.60M |
| June 30, 2024 | 249.10M |
| March 31, 2024 | 434.80M |
| December 31, 2023 | 287.50M |
| September 30, 2023 | 306.30M |
| June 30, 2023 | 295.60M |
| March 31, 2023 | 223.30M |
| December 31, 2022 | 368.80M |
| September 30, 2022 | 771.80M |
| June 30, 2022 | 790.10M |
| March 31, 2022 | 885.80M |
| December 31, 2021 | 977.00M |
| September 30, 2021 | 880.50M |
| June 30, 2021 | 1.005B |
| March 31, 2021 | 1.10B |
| December 31, 2020 | 972.00M |
| September 30, 2020 | 797.10M |
| June 30, 2020 | 765.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 642.80M |
| December 31, 2019 | 626.30M |
| September 30, 2019 | 546.48M |
| June 30, 2019 | 458.05M |
| March 31, 2019 | 462.06M |
| December 31, 2018 | 438.52M |
| September 30, 2018 | 423.17M |
| June 30, 2018 | 428.35M |
| March 31, 2018 | 363.02M |
| December 31, 2017 | 373.00M |
| September 30, 2017 | 344.25M |
| June 30, 2017 | 342.08M |
| March 31, 2017 | 337.48M |
| December 31, 2016 | 345.70M |
| September 30, 2016 | 360.72M |
| June 30, 2016 | 378.27M |
| March 31, 2016 | 415.34M |
| December 31, 2015 | 382.07M |
| September 30, 2015 | 381.26M |
| June 30, 2015 | 365.55M |
| March 31, 2015 | 342.52M |
| December 31, 2014 | 331.73M |
| September 30, 2014 | 294.92M |
| June 30, 2014 | 258.43M |
| March 31, 2014 | 248.10M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Exelixis, Inc. | 2.350B |
| Capricor Therapeutics, Inc. | -2.095M |
| ADMA Biologics, Inc. | 331.27M |
| Akebia Therapeutics, Inc. | 172.88M |
| Arcutis Biotherapeutics, Inc. | 422.88M |